Lantheus Holdings (LNTH) Change in Inventory (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Change in Inventory of -$2.1 million for Q1 2026, down 660.07% year-over-year from $377273.0 in Q1 2025, and down 169.48% quarter-over-quarter from $3.0 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Inventory (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Change in Inventory for 13 consecutive years, with -$2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 660.07% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at $7.5 million (up 223.42% YoY), while the FY2025 annual figure was $9.4 million, up 250.79% from the prior year.
- Change in Inventory eased to -$2.1 million in Q1 2026 per LNTH's latest filing, from $3.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $12.1 million in Q2 2023 and bottomed at -$4.4 million in Q4 2024.
- Historically, Change in Inventory has averaged $3.2 million across 5 years, with a median of $2.7 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Inventory jumped 3100.79% — and 2026, when it plunged 660.07%.
- Lantheus Holdings' Change in Inventory stood at $2.8 million in 2022, then surged by 259.78% to $10.2 million in 2023, then tumbled by 143.33% to -$4.4 million in 2024, then surged by 168.63% to $3.0 million in 2025, then slumped by 169.48% to -$2.1 million in 2026.
- Business Quant data shows LNTH's Change in Inventory at -$2.1 million in Q1 2026, $3.0 million in Q4 2025, and $915000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.80 Bn | 40.14 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.94 Bn | 241.86 Mn | -3.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.30 Mn |
| Jun 30, 2026 | -3.30 Mn |
| Mar 31, 2026 | -2.11 Mn |
| Mar 31, 2026 | -2.11 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 915,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | 5.69 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -4.43 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -874,000.00 |
| Sep 30, 2024 | -874,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Mar 31, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.49 Mn |